Rapid Nexus Secures VA and DoD Contracts and Launches Commercial Deployment of FDA-Cleared Wound Technology
Deployment across VA and Department of Defense systems brings Rapid Nexus into real-world clinical use, expanding access to its FDA-cleared Hemastyl® treatment for complex wound cases BREA, Calif., April 29, 2026 /PRNewswire/ -- Rapid Nexus Nanotech Wound Solutions, Inc., a...
View original →